[Efficiency of new forms of madopar in Parkinson's disease].
The paper presents estimation of the efficiency of some new forms of madopar (madopar dispergative--Mad-Dis, Mad-HBS) in 26 patients with Parkinson's disease by methods of motor potential, autonomic tests. A good tolerance of Mad-HBS was found. Its administration neither causes changes of autonomic indices nor aggravates symptomatology of cardiovascular disease. A single dose of Mad-Dis may serve as a predictor for a positive result of DOPA-containing preparations in a certain group of patients with Parkinson's disease.